BNXTF

Company Profile

BNXTF had its IPO on under the ticker symbol BNXTF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. BNXTF has a staff strength of 0 employees.

Stock update

Shares of BNXTF opened at $0.31 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.29 - $0.31, and closed at $0.29.

This is a +1.39% increase from the previous day's closing price.

A total volume of 1,925 shares were traded at the close of the day’s session.

In the last one week, shares of BNXTF have slipped by -6.23%.

BNXTF's Key Ratios

BNXTF has a market cap of $54.90 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months BNXTF’s revenue was $297442 with a gross profit of $199478 and an EBITDA of $-6404293. The EBITDA ratio measures BNXTF's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BNXTF’s operating margin was 0% while its return on assets stood at -72.46% with a return of equity of -397.02%.

In Q1, BNXTF’s quarterly earnings growth was a positive 0% while revenue growth was a negative 77.1%.

BNXTF’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BNXTF’s profitability.

BNXTF stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

BNXTF stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$3.19 million

Total Liabilities

$3.28 million

Operating Cash Flow

$0

Capital Expenditure

$1567

Dividend Payout Ratio

0%

BNXTF ended 2024 with $3.19 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.19 million while shareholder equity stood at $-2346308.00.

BNXTF ended 2024 with $0 in deferred long-term liabilities, $3.28 million in other current liabilities, in common stock, $-56097172.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.89 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $2.26 million.

BNXTF’s total current assets stands at $2.31 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $338488.00 compared to accounts payable of $147972.00 and inventory worth $0.

In 2024, BNXTF's operating cash flow was $0 while its capital expenditure stood at $1567.

Comparatively, BNXTF paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.29

52-Week High

$0.581

52-Week Low

$0.0014

Analyst Target Price

$

BNXTF stock is currently trading at $0.29 per share. It touched a 52-week high of $0.581 and a 52-week low of $0.581. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.3 and 200-day moving average was $0.39 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 695.1% of the company’s stock are held by insiders while 0% are held by institutions.